These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 1735771)
41. [Findings of cerebrospinal fluid in the diagnosis of multiple sclerosis]. Drulović J; Stojsavljević N; Dujmović I; Sokić D; Mavra M; Lević Z Srp Arh Celok Lek; 1995; 123(7-8):191-3. PubMed ID: 17974427 [TBL] [Abstract][Full Text] [Related]
42. T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid. Holmøy T; Vandvik B; Vartdal F Mult Scler; 2003 Jun; 9(3):228-34. PubMed ID: 12814167 [TBL] [Abstract][Full Text] [Related]
43. Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus. Hagihara M; Shimura T; Yamamoto K; Sujirachato K; Tsuji S; Yamamura M; Tsuji K Tokai J Exp Clin Med; 1993 Jun; 18(1-2):61-4. PubMed ID: 7940609 [TBL] [Abstract][Full Text] [Related]
44. Approach to discriminate subgroups in multiple sclerosis with cerebrospinal fluid (CSF) basic inflammation indices and TNF-alpha, IL-1beta, IL-6, IL-8. Kleine TO; Zwerenz P; Graser C; Zöfel P Brain Res Bull; 2003 Aug; 61(3):327-46. PubMed ID: 12909303 [TBL] [Abstract][Full Text] [Related]
45. Soluble class I antigen secretion by peripheral blood lymphocytes in multiple sclerosis. Alvarez-Cermeño JC; Brieva JA; Villar LM; Roldán E; Bootello A; González-Porqué P Eur Neurol; 1993; 33(3):229-31. PubMed ID: 8467843 [TBL] [Abstract][Full Text] [Related]
46. Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerebrospinal fluid. Reiber H; Teut M; Pohl D; Rostasy KM; Hanefeld F Mult Scler; 2009 Dec; 15(12):1466-80. PubMed ID: 19995844 [TBL] [Abstract][Full Text] [Related]
47. In vivo relationship of tumor necrosis factor-alpha to blood-brain barrier damage in patients with active multiple sclerosis. Sharief MK; Thompson EJ J Neuroimmunol; 1992 May; 38(1-2):27-33. PubMed ID: 1577950 [TBL] [Abstract][Full Text] [Related]
48. Neuroimmunological findings in Guillain Barré syndrome, multiple sclerosis, and idiopathic polyneuropathies. Dorta-Contreras A; Silva-Somoza R Mol Chem Neuropathol; 1996; 28(1-3):279-84. PubMed ID: 8871970 [TBL] [Abstract][Full Text] [Related]
49. Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis. Ciprandi G; Colombo BM; Contini P; Cagnati P; Pistorio A; Puppo F; Murdaca G Allergy; 2008 Oct; 63(10):1335-8. PubMed ID: 18782112 [TBL] [Abstract][Full Text] [Related]
50. Cerebrospinal fluid thrombomodulin and sVCAM-1 in different clinical stages of multiple sclerosis patients. Frigerio S; Ariano C; Bernardi G; Ciusani E; Massa G; La Mantia L; Salmaggi A J Neuroimmunol; 1998 Jul; 87(1-2):88-93. PubMed ID: 9670849 [TBL] [Abstract][Full Text] [Related]
51. The Multiple Sclerosis Cooperative Etiological Study in Italy: preliminary analysis of CSF findings. Trojano M; Logroscino GC; Pisicchio L; Rosato A; Bordo B; Citterio A; Amato MP; Livrea P Ital J Neurol Sci; 1987 Jun; Suppl 6():71-6. PubMed ID: 3654180 [TBL] [Abstract][Full Text] [Related]
52. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662 [TBL] [Abstract][Full Text] [Related]
53. Soluble HLA class I and class II concentrations in factor VIII and PCC preparations. Westhoff U; Grosse-Wilde H Vox Sang; 1995; 68(2):73-6. PubMed ID: 7762224 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of central nervous system vaccinia antibody synthesis in multiple sclerosis patients. Thompson JA; Glasgow LA; Bray PF Neurology; 1977 Mar; 27(3):227-9. PubMed ID: 557758 [TBL] [Abstract][Full Text] [Related]
55. Gamma delta T cell distribution in cerebrospinal fluid and peripheral blood of patients with multiple sclerosis. Droogan AG; Crockard AD; Hawkins SA; McNeill TA J Neurol Sci; 1994 Nov; 126(2):172-7. PubMed ID: 7853024 [TBL] [Abstract][Full Text] [Related]
56. Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal. Chalon MP; Sindic CJ; Laterre EC Acta Neurol Scand; 1993 Feb; 87(2):77-82. PubMed ID: 8442399 [TBL] [Abstract][Full Text] [Related]
57. rhG-CSF effect on mixed lymphocyte cultures and circulating soluble HLA antigen levels in volunteer stem cell donors. Lindemann M; Rebmann V; Ottinger HD; Schmolke K; Kreuzfelder E; Grosse-Wilde H Exp Hematol; 2004 Nov; 32(11):1103-9. PubMed ID: 15539089 [TBL] [Abstract][Full Text] [Related]
58. The relationship of interleukin-2 and soluble interleukin-2 receptors to intrathecal immunoglobulin synthesis in patients with multiple sclerosis. Sharief MK; Hentges R; Thompson EJ J Neuroimmunol; 1991 Apr; 32(1):43-51. PubMed ID: 2002090 [TBL] [Abstract][Full Text] [Related]
59. Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma. Brieva JA; Villar LM; Leoro G; Alvarez-Cermeño JC; Roldán E; Gonzalez-Porqué P Clin Exp Immunol; 1990 Nov; 82(2):390-5. PubMed ID: 2122936 [TBL] [Abstract][Full Text] [Related]
60. Soluble CD40 ligand contributes to blood-brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder. Masuda H; Mori M; Uchida T; Uzawa A; Ohtani R; Kuwabara S J Neuroimmunol; 2017 Apr; 305():102-107. PubMed ID: 28284329 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]